Researchers at Cambridge University have developed a novel vaccine technique they believe could offer broad protection against future pandemics. The approach focuses on targeting highly conserved viral proteins – parts of viruses that remain consistent across different strains and even viral families – rather than focusing on rapidly mutating surface proteins. This “master key” strategy aims to create a universal vaccine capable of eliciting an immune response against a wide range of potential pandemic threats. Early laboratory tests have demonstrated promising results, triggering neutralizing antibodies against multiple viruses. Scientists suggest this technique could significantly reduce the time needed to develop effective vaccines during a new outbreak, potentially preventing widespread illness and death. Further research and clinical trials are necessary to confirm the efficacy and safety of this innovative vaccine platform. The findings were published today in the journal *Science*.